Andrew Serafin

Insider Reports History

Location
Plymouth Meeting, PA
Signature
/s/ Christian Ulrich, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Serafin:

Company Role Class Num Shares Value Price $ Report Date Ownership
Harmony Biosciences Holdings, Inc. CHIEF STRATEGY OFFICER Restricted Stock Units 7,800 $417,361 $40.13 25 Jan 2026 Direct
Harmony Biosciences Holdings, Inc. CHIEF STRATEGY OFFICER Common Stock 1,474 $54,272 $36.82 25 Jan 2026 Direct
Harmony Biosciences Holdings, Inc. CHIEF STRATEGY OFFICER Stock Option 42,600 22 Jan 2026 Direct

Insider Reports Filed by Andrew Serafin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HRMY Harmony Biosciences Holdings, Inc. 22 Jan 2026 8 -$82,550 4 CHIEF STRATEGY OFFICER 26 Jan 2026, 16:48
HRMY Harmony Biosciences Holdings, Inc. 24 Jan 2025 5 -$32,879 4 CHIEF STRATEGY OFFICER 28 Jan 2025, 12:51
HRMY Harmony Biosciences Holdings, Inc. 24 Jan 2024 2 $0 4 CHIEF STRATEGY OFFICER 26 Jan 2024, 16:54
HRMY Harmony Biosciences Holdings, Inc. 02 Dec 2022 4 -$1,972,740 4 CHIEF STRATEGY OFFICER 05 Dec 2022, 15:10